A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)

Chang Gung Medical Foundation. Linkou ( Site 0952), Taoyuan District

National Cheng Kung University Hospital ( Site 0955), Tainan City

Chang Gung Medical Foundation - Kaohsiung ( Site 0956), Kaohsiung City

Akershus universitetssykehus ( Site 1352), Loerenskog

Westmead Hospital ( Site 0057), Westmead

Sandton Oncology Medical Group PTY LTD ( Site 1501), Sandton

Western Health-Sunshine & Footscray Hospitals ( Site 0052), St Albans

Frankston Hospital ( Site 0056), Frankston

Royal Brisbane and Women s Hospital ( Site 0058), Herston

Queen Elizabeth Hospital ( Site 0050), Woodville South

Helse Bergen HF - Haukeland univeritetssykehus ( Site 1353), Bergen

St John of God Subiaco Hospital ( Site 0051), Perth

Cancer Care Langenhoven Drive Oncology Centre ( Site 1504), Port Elizabeth

St Olavs Hospital ( Site 1354), Trondheim

Cape Town Oncology Trials Pty Ltd ( Site 1506), Kraaifontein

Cancercare Rondebosch Oncology ( Site 1509), Rondebosch

Universitetssykehuset i Nord Norge. ( Site 1355), Tromsø

National Taiwan University Hospital ( Site 0950), Taipei

Memorial Sloan Kettering Cancer Center ( Site 1703), New York

Taipei Veterans General Hospital ( Site 0951), Taipei

Georgetown University Hospital ( Site 1148), Washington D.C.

Sibley Memorial Hospital ( Site 1143), Washington D.C.

Istituto Clinico Humanitas - Cancer Center ( Site 0555), Rozzano

ASST Grande Ospedale Metropolitano Niguarda ( Site 0550), Milan

Inova Schar Cancer Institute ( Site 1130), Fairfax

Katholisches Marienkrankenhaus gGmbH ( Site 1257), Hamburg

VCU Health Adult Outpatient Pavillion ( Site 1712), Richmond

Blue Ridge Cancer Care ( Site 1718), Roanoke

Ukrainian Center of Tomotherapy ( Site 1658), Kropyvnytskyi

Hospital Clinico San Carlos ( Site 0902), Madrid

Hospital Universitario 12 de Octubre ( Site 0901), Madrid

MUSC Hollings Cancer Center ( Site 1715), Charleston

Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 1118), Marietta

CHU Bordeaux Haut-Leveque ( Site 0305), Pessac

Goztepe Prof.Dr. Suleyman Yalcin Sehir Hastanesi ( Site 1002), Istanbul

Philipps-Universitaet Marburg. ( Site 1252), Marburg

Ege Universitesi Tip Fakultesi Hastanesi ( Site 1006), Izmir

The West Clinic, PLLC dba West Cancer Center ( Site 1149), Germantown

Klinikum Wolfsburg ( Site 1256), Wolfsburg

Norton Cancer Institute ( Site 1139), Louisville

China Medical University Hospital ( Site 0953), Taichung

Hospital Universitario Virgen Macarena ( Site 0906), Seville

Kliniken Maria Hilf GmbH ( Site 1255), Mönchengladbach

CHU Hotel Dieu Nantes ( Site 0303), Nantes

Beacon Hospital Sdn Bhd ( Site 1305), Petaling Jaya

Municipal Non-Profit Enterprise City Clinical Hospital 4 of Dnipro City Council ( Site 1657), Dnipro

Johanniter Krankenhaus Bonn ( Site 1254), Bonn

Pantai Hospital Kuala Lumpur ( Site 1303), Bangsar

University Malaya Medical Centre ( Site 1301), Kuala Lumpur

Institut Kanser Negara - National Cancer Institute ( Site 1302), Putrajaya

Odessa Regional Clinical Hospital ( Site 1664), Odesa

IRCCS Casa Sollievo della Sofferenza ( Site 0554), San Giovanni Rotondo

Hopital Europeen Georges Pompidou ( Site 0300), Paris

MI Precarpathian Clinical Oncology Center ( Site 1654), Ivano-Frankivsk

Universita degli Studi della Campania Luigi Vanvitelli-UOC Oncoematologia ( Site 0556), Napoli

LMU Klinikum Grosshadern der Universitaet Muenchen ( Site 1253), Munich

Institut du Cancer Avignon-Provence ( Site 0306), Avignon

Intermountain Medical Center ( Site 1707), Murray

CHU Poitiers ( Site 0304), Poitiers

A.O. di Rilievo Nazionale e di alta Specializzazione Garibaldi ( Site 0553), Catania

Oregon Health & Science University ( Site 1141), Portland

Seattle Cancer Care Alliance ( Site 1107), Seattle

SRBHI of Kirov Region Center of Oncology and medical radiology ( Site 0854), Kirov

Main Military Clinical Hospital n.a. N.N.Burdenko ( Site 0870), Moscow

FSBI-FRCC of Special Types Med. Care and Technologies FMBA of Russia ( Site 0851), Moscow

Jilin Cancer Hospital ( Site 1163), Changchun

Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 0850), Yaroslavl

"SHBI Leningrad Regional Clinical Oncology Dispensary n.a. L.D. Roman-Clinical Trials Department (", Saint Petersburg

City Hospital #40 ( Site 0853), Saint Petersburg

Clinical Research Center of specialized types medical care-Oncology ( Site 0860), Saint Petersburg

Shanghai Tenth People's Hospital ( Site 1170), Shanghai

Fudan University Shanghai Cancer Center ( Site 1176), Shanghai

Changzhou Cancer Hospital-Department of Oncology ( Site 1183), Changzhou

Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 1185), Wuxi

The Second Affiliated Hospital of Anhui Medical University ( Site 1179), Hefei

Jinan Central Hospital ( Site 1167), Jinan

Tianjin Medical University Cancer Institute and Hospital ( Site 1161), Tianjin

Zhejiang Cancer Hospital ( Site 1180), Hangzhou

Sir Run Run Shaw Hospital-Medical Oncology ( Site 1173), Hangzhou

West China Hospital Sichuan University ( Site 1172), Chengdu

Fujian Province Cancer Hospital ( Site 1178), Fuzhou

Chongqing Cancer Hospital ( Site 1151), Chongqing

Xiangya Hospital Central South University ( Site 1171), Changsha

Hunan Cancer Hospital ( Site 1174), Changsha

The Third Xiangya Hospital of Central South University ( Site 1175), Changsha

Wuhan Union Hospital Cancer Center ( Site 1162), Wuhan

Hubei Cancer Hospital ( Site 1152), Wuhan

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 0871), Ufa

Sun Yat-Sen University Cancer Center ( Site 1150), Guangzhou

Southern Medical University Nanfang Hospital ( Site 1154), Guangzhou

The Sixth Affiliated Hospital of Sun Yat-sen University ( Site 1159), Guangzhou

Guangxi Medical University Affiliated Tumor Hospital ( Site 1158), Nanning

Hainan General Hospital ( Site 1177), Haikou

Tomsk National Research Medical Center of Russian Academy of Sciences ( Site 0872), Tomsk

Yunnan Province Cancer Hospital-Colorectal surgery ( Site 1169), Kunming

IC La Serena Research ( Site 0202), La Serena

Rambam Health Care Campus-Oncology Division ( Site 0500), Haifa

Bnei Zion Medical Center ( Site 0506), Haifa

Centro Investigacion Cancer James Lind ( Site 0204), Temuco

Rabin Medical Center ( Site 0503), Petah Tikva

Chaim Sheba Medical Center ( Site 0501), Ramat Gan

Clinica Puerto Montt ( Site 0211), Port Montt

Kindai University Hospital ( Site 0607), Sayama

Sourasky Medical Center ( Site 0502), Tel Aviv

Fundacion Arturo Lopez Perez FALP ( Site 0208), Santiago

Oncovida ( Site 0209), Santiago

Assuta Ashdod Public ( Site 0507), Ashdod

Clínica Vespucio ( Site 0205), Santiago

Pontificia Universidad Catolica de Chile ( Site 0206), Santiago

Bradfordhill ( Site 0200), Santiago

Hadassa Ein Karem Medical Center ( Site 0504), Jerusalem

Rutgers Cancer Institute of New Jersey ( Site 1105), New Brunswick

UT Southwestern Medical Center ( Site 1709), Dallas

London Regional Cancer Program - London HSC ( Site 0154), London

The Ottawa Hospital ( Site 0151), Ottawa

Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0155), Toronto

Masarykuv onkologicky ustav ( Site 1203), Brno

Fakultni nemocnice v Motole ( Site 1201), Prague

Fakultni nemocnice Hradec Kralove ( Site 1207), Hradec Králové

Fakultni nemocnice Olomouc ( Site 1204), Olomouc

Fakultni nemocnice Kralovske Vinohrady ( Site 1208), Prague

Fakultni Thomayerova nemocnice ( Site 1205), Prague

Fakultni nemocnice Na Bulovce ( Site 1202), Prague

Universitätsklinikum Halle ( Site 1251), Halle

Policlinico Gemelli di Roma ( Site 0552), Roma

National Cancer Center Hospital East ( Site 0600), Kashiwa

Kagawa University Hospital ( Site 0608), Kita-gun

Saitama Prefectural Cancer Center ( Site 0603), Kitaadachi-gun

Shizuoka Cancer Center ( Site 0605), Sunto-gun,

National Hospital Organization Kyushu Cancer Center ( Site 0609), Fukuoka

National Cancer Center Hospital ( Site 0601), Tokyo

Japanese Foundation for Cancer Research ( Site 0602), Tokyo

Oslo Universitetssykehus HF. Ulleval ( Site 1351), Oslo

Asan Medical Center ( Site 0650), Songpagu

Seoul National University Hospital ( Site 0653), Seoul

Severance Hospital ( Site 0652), Seoul

Samsung Medical Center ( Site 0651), Seoul

Hospital Universitari Vall d Hebron ( Site 0900), Barcelona

Hospital Sant Pau i la Santa Creu ( Site 0905), Barcelona

Baskent Universitesi Dr. Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 1007), Adana

Acibadem Adana Hastanesi ( Site 1008), Adana

Gulhane Egitim ve Arastirma Hastanesi ( Site 1009), Ankara

Hacettepe Universitesi Tip Fakultesi ( Site 1003), Ankara

Ankara Sehir Hastanesi ( Site 1005), Ankara

Antalya Egitim ve Arastirma Hastanesi ( Site 1010), Antalya

University College London Hospitals NHS Foundation Trust ( Site 1056), London

Royal Marsden NHS Foundation Trust ( Site 1064), London

Imperial College Healthcare NHS Trust - Hammersmith Hospital ( Site 1052), London

Royal Marsden NHS Trust ( Site 1063), Sutton

University Hospital Coventry & Warwickshire ( Site 1062), Coventry

Velindre Cancer Centre ( Site 1058), Cardiff

Leeds Teaching Hospitals NHS Trust ( Site 1050), Leeds